Product Code: MD9504
The global ultrasound needle guides market reached US$ 372.53 million in 2024 and is expected to reach US$ 866.31 million by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
Ultrasound needle guides are instruments used in ultrasound-guided procedures to align a needle with the ultrasound beam, ensuring it is within the ultrasound's field of view. This improves needle visualization, reduces procedure time, and enhances intervention accuracy, facilitating safe and efficient needle puncture.
Market Dynamics: Drivers & Restraints
Rise in Technological Advancements
The global ultrasound needle guides market is growing due to technological advancements in imaging, artificial intelligence (AI), and device design. High-resolution ultrasound systems with improved image quality and penetration depth enable precise needle guidance and visualization. Advanced features like elastography and Doppler imaging enhance diagnostic capabilities, making ultrasound-guided procedures more versatile and effective. AI and machine learning in ultrasound devices improve efficiency by assisting with real-time image analysis, needle trajectory prediction, and automatic adjustments based on patient anatomy.
For instance, in September 2024, RIVANNA secured a patent for an advanced ultrasound-guided needle insertion system, aiming to significantly improve the accuracy and safety of needle-based medical procedures.
High Cost and Limited Accessibility in Low-Income Regions
Ultrasound systems and needle guide accessories are expensive, especially in low- and middle-income countries, which often face limited healthcare infrastructure and budget constraints, hindering widespread adoption and creating disparities in access to advanced ultrasound-guided interventions.
Segment Analysis
The global ultrasound needle guides market is segmented based on product type, application, end-user, and region.
Product Type:
The disposable needle guides from the product type segment is expected to dominate the ultrasound needle guides market with the highest market share.
Disposable needle guides are medical accessories made from medical-grade plastic, pre-sterilized to ensure safety and minimize cross-contamination. They assist in precise needle direction during ultrasound-guided procedures, aligning the needle path with the ultrasound beam, improving accuracy, and reducing procedural errors.
The disposable needle guides market is being driven by product launches, increasing focus on infection control and hospital-acquired infection prevention. Regulatory bodies and healthcare institutions are promoting single-use devices to reduce sterilization costs and comply with safety standards. The convenience and time efficiency of disposable guides, coupled with increasing procedure volumes, are driving market demand.
Geographical Analysis
North America is expected to hold a significant position in the ultrasound needle guides market, with the highest market share
The ultrasound needle guides market in North America is fueled by advanced healthcare infrastructure, high imaging technology adoption, and minimally invasive procedures. The region benefits from significant healthcare investments, skilled professionals, and supportive reimbursement policies. The rising prevalence of chronic diseases like cancer and cardiovascular conditions, which often require image-guided biopsies or catheter placements, further increases the demand for needle guides in clinical settings.
For instance, in November 2023, DeepSight Technology introduced its ultrasound-guided needle technology, NeedleVue, which offers safety in directed interventional tool guidance. It combines advanced sensor technology with interventional devices, enabling real-time placement verification and reducing procedural guesswork.
Competitive Landscape
The major global players in the ultrasound needle guides market include CIVCO Medical Solutions, GE Healthcare, Aspen Surgical Products, Inc., FUJIFILM Sonosite, Inc., Becton, Dickinson and Company (BD), Argon Medical Devices, Remington Medical Inc., GEOTEK Medical, Rocket Medical, and BIRR, among others.
Key Developments
- In July 2024, Intelligent Ultrasound (IU) launched NeedleTrainer 2.6, a new training solution for ultrasound-guided needling. The all-in-one training tool offers improved applicability across various needling practices and a new mode and e-learning for common vascular access procedures. It uses non-invasive needle insertion during real-time scanning on a real subject.
Why Purchase the Report?
- Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-world Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global ultrasound needle guides market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
Table of Contents
1. Market Introduction and Scope
- 1.1. Objectives of the Report
- 1.2. Report Coverage & Definitions
- 1.3. Report Scope
2. Executive Insights and Key Takeaways
- 2.1. Market Highlights and Strategic Takeaways
- 2.2. Key Trends and Future Projections
- 2.3. Snippet by Product Type
- 2.4. Snippet by Application
- 2.5. Snippet by End User
- 2.6. Snippet by Region
3. Dynamics
- 3.1. Impacting Factors
- 3.1.1. Drivers
- 3.1.1.1. Rise in the Technological Advancements
- 3.1.1.2. Rising Adoption of Minimally Invasive Procedures
- 3.1.2. Restraints
- 3.1.2.1. High Cost and Limited Accessibility in Low-Income Regions
- 3.1.2.2. Regulatory Challenges
- 3.1.3. Opportunity
- 3.1.3.1. Integration of AI with Ultrasound for Enhanced Targeting
- 3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
- 4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest largest-selling Brand
- 4.1.3. Market leaders with established Product
- 4.2. CXO Perspectives
- 4.3. Latest Developments and Breakthroughs
- 4.4. Case Studies/Ongoing Research
- 4.5. Regulatory and Reimbursement Landscape
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia Pacific
- 4.5.4. Latin America
- 4.5.5. Middle East & Africa
- 4.6. Porter's Five Force Analysis
- 4.7. Supply Chain Analysis
- 4.8. Patent Analysis
- 4.9. SWOT Analysis
- 4.10. Unmet Needs and Gaps
- 4.11. Recommended Strategies for Market Entry and Expansion
- 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
- 4.13. Pricing Analysis and Price Dynamics
- 4.14. Key Opinion Leaders
5. By Product Type
- 5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 5.1.2. Market Attractiveness Index, By Product Type
- 5.2. Disposable Needle Guides*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 5.3. Reusable Needle Guides
6. By Application
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
- 6.2. Tissue Biopsy*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Fluid Aspiration
- 6.4. Vascular Access Procedures
- 6.5. Nerve Block and Regional Anesthesia
- 6.6. Others
7. By End User
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 7.1.2. Market Attractiveness Index, By End User
- 7.2. Hospitals and Clinics*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Ambulatory Surgical Centers
- 7.4. Diagnostic Imaging Centers
- 7.5. Others
8. Regional Market Analysis and Growth Opportunities
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
- 8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.2.6.1. U.S.
- 8.2.6.2. Canada
- 8.2.6.3. Mexico
- 8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.3.6.1. Germany
- 8.3.6.2. U.K.
- 8.3.6.3. France
- 8.3.6.4. Spain
- 8.3.6.5. Italy
- 8.3.6.6. Rest of Europe
- 8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.4.6.1. Brazil
- 8.4.6.2. Argentina
- 8.4.6.3. Rest of Latin America
- 8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.5.6.1. China
- 8.5.6.2. India
- 8.5.6.3. Japan
- 8.5.6.4. South Korea
- 8.5.6.5. Rest of Asia-Pacific
- 8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9. Competitive Landscape and Market Positioning
- 9.1. Competitive Overview and Key Market Players
- 9.2. Market Share Analysis and Positioning Matrix
- 9.3. Strategic Partnerships, Mergers & Acquisitions
- 9.4. Key Developments in Product Portfolios and Innovations
- 9.5. Company Benchmarking
10. Company Profiles
- 10.1. CIVCO Medical Solutions*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
- 10.1.2.1. Product Description
- 10.1.2.2. Product Key Performance Indicators (KPIs)
- 10.1.2.3. Historic and Forecasted Product Sales
- 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
- 10.1.3.1. Company Revenue's
- 10.1.3.2. Geographical Revenue Shares
- 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
- 10.1.4.1. Mergers & Acquisitions
- 10.1.4.2. Key Product Development Activities
- 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
- 10.2. GE Healthcare
- 10.3. Aspen Surgical Products, Inc
- 10.4. FUJIFILM Sonosite, Inc
- 10.5. Becton, Dickinson, and Company (BD)
- 10.6. Argon Medical Devices
- 10.7. Remington Medical Inc
- 10.8. GEOTEK Medical
- 10.9. Rocket Medical
- 10.10. BIRR
LIST NOT EXHAUSTIVE
11. Assumption and Research Methodology
- 11.1. Data Collection Methods
- 11.2. Data Triangulation
- 11.3. Forecasting Techniques
- 11.4. Data Verification and Validation
12. Appendix
- 12.1. About Us and Services
- 12.2. Contact Us